Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
70,886,873
-
Number of holders
-
178
-
Total 13F shares, excl. options
-
55,189,855
-
Shares change
-
+1,488,071
-
Total reported value, excl. options
-
$2,186,203,412
-
Value change
-
+$48,206,866
-
Put/Call ratio
-
58.19%
-
Number of buys
-
89
-
Number of sells
-
-91
-
Price
-
$39.62
Significant Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) as of Q4 2021
222 filings reported holding HCAT - Health Catalyst, Inc. - Common Stock, par value $0.001 per share as of Q4 2021.
Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 178 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55,189,855 shares
of 70,886,873 outstanding shares and own 77.86% of the company stock.
Largest 10 shareholders include FMR LLC (7,426,586 shares), BlackRock Inc. (4,699,392 shares), VANGUARD GROUP INC (4,282,739 shares), WELLINGTON MANAGEMENT GROUP LLP (3,614,005 shares), Capital Research Global Investors (3,392,000 shares), ALLIANCEBERNSTEIN L.P. (3,124,879 shares), Clearbridge Investments, LLC (2,244,145 shares), JANUS HENDERSON GROUP PLC (1,378,379 shares), RIVERBRIDGE PARTNERS LLC (1,113,456 shares), and abrdn plc (1,097,447 shares).
This table shows the top 178 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.